These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29872435)

  • 21. Cytokine production in patients with inflammatory bowel disease.
    Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
    Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies.
    Ellinghaus D; Zhang H; Zeissig S; Lipinski S; Till A; Jiang T; Stade B; Bromberg Y; Ellinghaus E; Keller A; Rivas MA; Skieceviciene J; Doncheva NT; Liu X; Liu Q; Jiang F; Forster M; Mayr G; Albrecht M; Häsler R; Boehm BO; Goodall J; Berzuini CR; Lee J; Andersen V; Vogel U; Kupcinskas L; Kayser M; Krawczak M; Nikolaus S; Weersma RK; Ponsioen CY; Sans M; Wijmenga C; Strachan DP; McArdle WL; Vermeire S; Rutgeerts P; Sanderson JD; Mathew CG; Vatn MH; Wang J; Nöthen MM; Duerr RH; Büning C; Brand S; Glas J; Winkelmann J; Illig T; Latiano A; Annese V; Halfvarson J; D'Amato M; Daly MJ; Nothnagel M; Karlsen TH; Subramani S; Rosenstiel P; Schreiber S; Parkes M; Franke A
    Gastroenterology; 2013 Aug; 145(2):339-47. PubMed ID: 23624108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.
    Ehm P; Nalaskowski MM; Wundenberg T; Jücker M
    Nucleus; 2015; 6(2):154-64. PubMed ID: 25723258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of lipid phosphatase SHIP1 expands myeloid-derived suppressor cells and attenuates rheumatoid arthritis in mice.
    So EY; Sun C; Wu KQ; Dubielecka PM; Reginato AM; Liang OD
    Am J Physiol Cell Physiol; 2021 Sep; 321(3):C569-C584. PubMed ID: 34288720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIR-B Regulates CD4
    Uddin J; Tomar S; Sharma A; Waggoner L; Ganesan V; Marella S; Yang Y; Noah T; Vanoni S; Patterson A; Zeng C; Foster PS; Newberry R; Bishu S; Kao JY; Rosen MJ; Denson L; King PD; Hoebe K; Divanovic S; Munitz A; Hogan SP
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1479-1502. PubMed ID: 34242819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
    Yoshimura T; Mitsuyama K; Sakemi R; Takedatsu H; Yoshioka S; Kuwaki K; Mori A; Fukunaga S; Araki T; Morita M; Tsuruta K; Yamasaki H; Torimura T
    Mediators Inflamm; 2021; 2021():8825374. PubMed ID: 33623482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia.
    Neubauer K; Bednarz-Misa I; Walecka-Zacharska E; Wierzbicki J; Agrawal A; Gamian A; Krzystek-Korpacka M
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective.
    Wasinger VC; Yau Y; Duo X; Zeng M; Campbell B; Shin S; Luber R; Redmond D; Leong RW
    Mol Cell Proteomics; 2016 Jan; 15(1):256-65. PubMed ID: 26530476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease.
    Kalla R; Adams AT; Ventham NT; Kennedy NA; White R; Clarke C; Ivens A; Bergemalm D; Vatn S; Lopez-Jimena B; ; Ricanek P; Vatn MH; Söderholm JD; Gomollón F; Nowak JK; Jahnsen J; Halfvarson J; McTaggart S; Ho GT; Buck A; Satsangi J
    J Crohns Colitis; 2020 Dec; 14(12):1724-1733. PubMed ID: 32598439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammation.
    Funderburg NT; Stubblefield Park SR; Sung HC; Hardy G; Clagett B; Ignatz-Hoover J; Harding CV; Fu P; Katz JA; Lederman MM; Levine AD
    Immunology; 2013 Sep; 140(1):87-97. PubMed ID: 23600521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
    Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
    Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease.
    Gonsky R; Fleshner P; Deem RL; Biener-Ramanujan E; Li D; Potdar AA; Bilsborough J; Yang S; McGovern DPB; Targan SR
    Gastroenterology; 2017 Jul; 153(1):219-232. PubMed ID: 28400196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico analysis of T-bet activity in peripheral blood mononuclear cells in patients with inflammatory bowel disease (IBD).
    Fernandez-Becker NQ; Moss AC
    In Silico Biol; 2009; 9(5-6):355-63. PubMed ID: 22430437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Two Additional Susceptibility Loci for Inflammatory Bowel Disease in a Chinese Population.
    Lan X; Lan X; Chang Y; Zhang X; Liu J; Vikash V; Wang W; Huang M; Wang X; Zhou F; Chen L; Zhao Q
    Cell Physiol Biochem; 2017; 41(5):2077-2090. PubMed ID: 28456797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease.
    Yokoyama M; Kimura MY; Ito T; Hayashizaki K; Endo Y; Wang Y; Yagi R; Nakagawa T; Kato N; Matsubara H; Nakayama T
    Front Immunol; 2020; 11():594297. PubMed ID: 33584659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study.
    Negm M; Bahaa A; Farrag A; Lithy RM; Badary HA; Essam M; Kamel S; Sakr M; Abd El Aaty W; Shamkh M; Basiony A; Dawoud I; Shehab H
    BMC Gastroenterol; 2022 Apr; 22(1):203. PubMed ID: 35462542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival.
    Pal Singh S; de Bruijn MJW; Velaso Gago da Graça C; Corneth OBJ; Rip J; Stadhouders R; Meijers RWJ; Schurmans S; Kerr WG; Ter Burg J; Eldering E; Langerak AW; Pillai SY; Hendriks RW
    J Immunol; 2020 Jan; 204(2):360-374. PubMed ID: 31836657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1.
    Renrick AN; Thounaojam MC; de Aquino MTP; Chaudhuri E; Pandhare J; Dash C; Shanker A
    Front Immunol; 2021; 12():607044. PubMed ID: 33717088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.